All Stories

  1. Frailty Redefines Risk Across the Weight Spectrum in Heart Failure
  2. Deep learning for atrioventricular regurgitation diagnosis: an external validation study
  3. Heart failure with supranormal ejection fraction: clinical characteristics and outcomes compared to mildly reduced and preserved ejection fraction
  4. Atherosclerotic Cardiovascular Diseases Are Associated With Incident Metastatic and Nonmetastatic Cancer
  5. Comparison between invasive cardiac output and left ventricular assist device flow parameter
  6. Considerations regarding safety with pulsed field ablation for atrial fibrillation
  7. A decade of follow-up: atrial fibrillation, pulmonary pressure, and the progression of tricuspid regurgitation
  8. Temporal Trends in Patient Characteristics and Clinical Outcomes of TAVR: Over a Decade of Practice
  9. Artificial Intelligence Assessment of Biological Age From Transthoracic Echocardiography: Discrepancies with Chronologic Age Predict Significant Excess Mortality
  10. Physical fitness is an independent predictor of chronic kidney disease development in apparently healthy individuals
  11. Low cardiorespiratory fitness is associated with elevated intraocular pressure among apparently healthy adults
  12. Non-Interventional Weight Changes Are Associated with Alterations in Serum Uric Acid Levels
  13. Utilizing Human-Induced Pluripotent Stem Cells to Study Cardiac Electroporation Pulsed-Field Ablation
  14. Transcatheter edge-to-edge mitral valve repair in patients with acute decompensated heart failure due to severe mitral regurgitation
  15. The safety of sodium glucose transporter 2 inhibitors and trends in clinical and hemodynamic parameters in patients with left ventricular assist devices
  16. Non-Interventional Weight Changes Are Associated with Alterations in Lipid Profiles and in the Triglyceride-to-HDL Cholesterol Ratio
  17. Echocardiography vs hemodynamic assessment of diastolic dysfunction
  18. Modifiers of the Association between E/e' Ratio and Survival among Patients with No Apparent Structural or Functional Cardiac Abnormality
  19. Comparison of MANTA versus Perclose Prostyle large‐bore vascular closure devices during transcatheter aortic valve implantation
  20. Levetiracetam Interaction with Direct Oral Anticoagulants: A Pharmacovigilance Study
  21. Atrial fibrillation in young hospitalized patients: Clinical characteristics, predictors of new onset, and outcomes
  22. Left atrial size predicts long-term outcome after balloon mitral valvuloplasty
  23. Serum Magnesium Is Associated with Long-Term Survival of Non-ST-Elevation Myocardial Infarction Patients
  24. Baseline renal function and the risk of cancer among apparently healthy middle-aged adults
  25. Guess What We Can Hear—Novel Voice Biomarkers for the Remote Detection of Disease
  26. Ischemic Stroke Risk in Patients on Direct Oral Anticoagulants with Levetiracetam: A Pharmacovigilance Study
  27. Mild renal impairment is associated with increased cardiovascular events and all-cause mortality following cancer diagnosis
  28. Investigation of cardiac arrhythmia events in patients treated with lamotrigine: FDA adverse event reporing system analysis
  29. Pseudo-discordance mimicking low-flow low-gradient aortic stenosis in transcatheter aortic valve replacement patients with severe symptomatic aortic stenosis
  30. Evaluation of coronary disease among patients undergoing transcatheter aortic valve implantation: propensity score matching analysis
  31. The real-world safety profile of sodium-glucose co-transporter-2 inhibitors among older adults (≥ 75 years): a retrospective, pharmacovigilance study
  32. Tricuspid Valve Repair by Chordal Grasping
  33. Serum uric acid significantly improves the accuracy of cardiovascular risk score models
  34. Usefulness of Coronary Artery Calcium Score to Rule Out Obstructive Coronary Artery Disease Before Transcatheter Aortic Valve Implantation
  35. Differential effect of high-frequency electroporation on myocardium vs. non-myocardial tissues
  36. A validated score to predict one-year and long-term mortality in patients with significant tricuspid regurgitation
  37. Management and outcome of patients with non-ST elevation myocardial infarction and intercurrent non-coronary precipitating events
  38. Early Invasive Strategy and Outcome of Non–ST-Segment Elevation Myocardial Infarction Patients With Chronic Kidney Disease
  39. Effects of Pulsed Electric Fields on the Coronary Arteries in Swine
  40. Parametric Study of Pulsed Field Ablation With Biphasic Waveforms in an In Vivo Heart Model: The Role of Frequency
  41. The Association of Severe Tricuspid Regurgitation with Poor Survival Is Modified by Right Ventricular Pressure and Function: Insights from SHEBAHEART Big Data
  42. Procedural and long‐term outcome among patients undergoing expedited trans‐catheter aortic valve replacement
  43. Bipolar Electroporation Across the Interventricular Septum
  44. Pacing burden and clinical outcomes after transcatheter aortic valve replacement—A real-world registry report
  45. The Authors Respond to Gnanaligham and Ahman
  46. Ventricular nanosecond pulsed electric field delivery using active fixation leads: a proof-of-concept preclinical study
  47. Clinical Predictors for Procedural Stroke and Implications for Embolic Protection Devices during TAVR: Results from the Multicenter Transcatheter Aortic Valve Replacement In-Hospital Stroke (TASK) Study
  48. Local Anesthesia versus Conscious Sedation among Patients Undergoing Transcatheter Aortic Valve Implantation—A Propensity Score Analysis
  49. CHA2DS2-VASC Score Predicts the Risk of Stroke in Patients Hospitalized to the Internal Medicine Department Without Known Atrial Fibrillation
  50. Noninvasive Voice Biomarker Is Associated With Incident Coronary Artery Disease Events at Follow-up
  51. Hemodynamic Changes After Left Ventricular Assist Device Implantation Among Heart Failure Patients With and Without Elevated Pulmonary Vascular Resistance
  52. Cardiac ablation with pulsed electric fields: principles and biophysics
  53. Diastolic Plateau – Invasive Hemodynamic Marker of Adverse Outcome Among Left Ventricular Assist Device Patients
  54. The Association of Moderate Aortic Stenosis with Poor Survival Is Modified by Age and Left Ventricular Function: Insights from SHEBAHEART Big Data
  55. Post–ST‐Segment–Elevation Myocardial Infarction Platelet Reactivity Is Associated With the Extent of Microvascular Obstruction and Infarct Size as Determined by Cardiac Magnetic Resonance Imaging
  56. The impact of diabetes on short-, intermediate- and long-term mortality following left ventricular assist device implantation
  57. Echocardiographic Ventricular Septal Motion Abnormalities Are Associated With Pre-Capillary Pulmonary Hypertension in Patients With Preserved Left Ventricular Function
  58. Pulmonary Hypertension Is Associated With Systemic Arterial Hypertension Among Patients With Normal Left Ventricular Diastolic Function
  59. Hyperglycaemic disorders associated with PCSK9 inhibitors: a real-world, pharmacovigilance study
  60. Clinical Predictors of Mortality in Prehospital Distress Calls by Emergency Medical Service Subscribers
  61. Adverse Cardiovascular and Pulmonary Events Associated With Chimeric Antigen Receptor T-Cell Therapy
  62. Clinical Outcome and Safety of Transcaval Access for Transcatheter Aortic Valve Replacement as Compared to Other Alternative Approaches
  63. Comparison of permanent pacemaker implantation rate after first and second generation of transcatheter aortic valve implantation–A retrospective cohort study
  64. Transcatheter Tricuspid Valve Annuloplasty: Show Me the Real-World Data
  65. Comparing High-Frequency With Monophasic Electroporation Protocols in an In Vivo Beating Heart Model
  66. Noninvasive Vocal Biomarker is Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection
  67. Cardiovascular Toxicities of Antiangiogenic Tyrosine Kinase Inhibitors: A Retrospective, Pharmacovigilance Study
  68. Transcatheter Aortic Valve Implantation During the COVID-19 Pandemic
  69. Reversible Atrioventricular Conduction Impairment Following Bipolar Nanosecond Electroporation of the Interventricular Septum
  70. Cardiorespiratory Fitness Is an Independent Predictor of Cardiovascular Morbidity and Mortality and Improves Accuracy of Prediction Models
  71. Retinal Microvascular Signs as Screening and Prognostic Factors for Cardiac Disease: A Systematic Review of Current Evidence
  72. Non-Invasive Voice Biomarker is Associated with Incident Coronary Artery Disease Events at Follow- Up
  73. Don’t Trust the Imaging
  74. TAVR review of reviews: A new view on the horizon
  75. Global, regional, and national burden of ischaemic heart disease and its attributable risk factors, 1990–2017: results from the Global Burden of Disease Study 2017
  76. Norton score and clinical outcomes following acute decompensated heart failure hospitalization
  77. Preoperative Statin Therapy and Heart Transplantation Outcomes
  78. Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre‐COVID‐19 reports
  79. High fitness might be associated with the development of new‐onset atrial fibrillation in obese non‐athletic adults
  80. Global, regional, and national prevalence, incidence, mortality, and risk factors for atrial fibrillation, 1990–2017: results from the Global Burden of Disease Study 2017
  81. Cardiorespiratory fitness and survival following cancer diagnosis
  82. Relation of Low Serum Magnesium to Mortality and Cardiac Allograft Vasculopathy Following Heart Transplantation
  83. Non-invasive vocal biomarker is associated with pulmonary hypertension
  84. Vocal Biomarker Is Associated With Hospitalization and Mortality Among Heart Failure Patients
  85. Sex Disparities in First Medical Contact of Patients with Suspected Acute Coronary Syndrome Using Telemedicine Technology
  86. Validation of cardiac damage classification and addition of albumin in a large cohort of patients undergoing transcatheter aortic valve replacement
  87. The impact of left ventricular ejection fraction on heart failure patients with pulmonary hypertension
  88. Metformin therapy in patients with diabetes mellitus is associated with a reduced risk of vasculopathy and cardiovascular mortality after heart transplantation
  89. Transcatheter Aortic Valve Replacement Outcomes in Patients With Native vs Transplanted Kidneys: Data From an International Multicenter Registry
  90. Improved long-term outcomes after heart transplantation utilizing donors with a traumatic mode of brain death
  91. Irreversible electroporation for catheter-based cardiac ablation: a systematic review of the preclinical experience
  92. Pulsed electric fields for cardiac ablation and beyond: A state-of-the-art review
  93. The association between fasting plasma glucose and glycated hemoglobin in the prediabetes range and future development of hypertension
  94. Outcomes of Transcatheter Aortic Valve Implantation in Patients With Low Versus Intermediate to High Surgical Risk
  95. Relation of Neutrophil to Lymphocyte Ratio to Risk of Incident Atrial Fibrillation
  96. Attenuated peripheral endothelial function among women treated with aromatase inhibitors for breast cancer
  97. 2D and 3D Echocardiography-Derived Indices of Left Ventricular Function and Shape
  98. Effect of percutaneous paravalvular leak closure on hemolysis
  99. A hybrid technique for treatment of commissural primary mitral regurgitation
  100. Elimination of Purkinje Fibers by Electroporation Reduces Ventricular Fibrillation Vulnerability
  101. Intrapulmonary Vein Ablation Without Stenosis: A Novel Balloon‐Based Direct Current Electroporation Approach
  102. Voice Signal Characteristics Are Independently Associated With Coronary Artery Disease
  103. Irreversible electroporation for the treatment of cardiac arrhythmias
  104. Wrist or Groin? Learning From the Wisdom of the Crowd
  105. De novo mitral regurgitation as a cause of heart failure exacerbation in patients with hypertrophic cardiomyopathy
  106. Early Referral to Coronary Artery Bypass Grafting Following Acute Coronary Syndrome, Trends and Outcomes from the Acute Coronary Syndrome Israeli Survey (ACSIS) 2000–2010
  107. Percutaneous closure of subannular rupture following transcatheter aortic valve implantation
  108. Percutaneous transcatheter biopsy for intracardiac mass diagnosis
  109. Outcomes of Transcatheter and Surgical Aortic Valve Replacement in Patients on Maintenance Dialysis
  110. Procedural trends, outcomes, and readmission rates pre-and post-FDA approval for MitraClip from the National Readmission Database (2013-14)
  111. Transcatheter and Surgical Management of Mitral Paravalvular Leak
  112. Building Blocks of Structural Intervention
  113. Left atrial pressure and predictors of survival after percutaneous mitral paravalvular leak closure
  114. Current and Future Use of Robotic Devices to Perform Percutaneous Coronary Interventions: A Review
  115. Acute Changes in Left Atrial Pressure After MitraClip Are Associated With Improvement in 6-Minute Walk Distance
  116. Gender disparities in the functional significance of anemia among apparently healthy adults
  117. Gender-Related Cardiovascular Risk in Healthy Middle-Aged Adults
  118. Poor Heart Rate Recovery Is Associated With the Development of New-Onset Atrial Fibrillation in Middle-Aged Adults
  119. Techniques and Outcomes of Percutaneous Aortic Paravalvular Leak Closure
  120. Optimization of Irreversible Electroporation Protocols for In-vivo Myocardial Decellularization
  121. Addition of beta-blockers to digoxin is associated with improved 1- and 10-year survival of patients hospitalized due to decompensated heart failure
  122. Metabolic syndrome, obesity, and the risk of cancer development
  123. Exercise systolic blood pressure variability is associated with increased risk for new-onset hypertension among normotensive adults
  124. Body mass index and the risk of new-onset atrial fibrillation in middle-aged adults
  125. Is Exercise Capacity Appropriate for Cardiovascular Risk Stratification ?
  126. Precipitating Factors for Acute Heart Failure Hospitalization and Long-Term Survival
  127. Clinical impact of diabetes mellitus in patients undergoing transcatheter aortic valve replacement
  128. Impaired fasting glucose and left ventricular diastolic dysfunction in middle-age adults: a retrospective cross-sectional analysis of 2971 subjects
  129. Obesity and exercise-induced ectopic ventricular arrhythmias in apparently healthy middle aged adults
  130. The association between cardiorespiratory fitness and cardiovascular risk may be modulated by known cardiovascular risk factors
  131. Vascular complications in steroid treated patients undergoing transfemoral aortic valve implantation
  132. Exercise Blood Pressure and the Risk for Future Hypertension Among Normotensive Middle‐Aged Adults
  133. Thrombophilic state in young patients with acute myocardial infarction
  134. Exercise haemodynamics may unmask the diagnosis of diastolic dysfunction among patients with pulmonary hypertension
  135. Survival after intervention in patients with low gradient severe aortic stenosis and preserved left ventricular function
  136. Low ALT blood levels predict long-term all-cause mortality among adults. A historical prospective cohort study
  137. Dynamic effects of point source electroporation on the rat brain tissue
  138. Relation Between Stroke Volume Index to Risk of Death in Patients With Low-Gradient Severe Aortic Stenosis and Preserved Left Ventricular Function
  139. The Unique Clinical Features and Outcome of Infectious Endocarditis and Vertebral Osteomyelitis Co-infection
  140. Cardiac stress test is normal in pre‐motor Parkinson's disease
  141. Time-dependent relation between smoking cessation and improved exercise tolerance in apparently healthy middle-age men and women
  142. Time dependent changes in high density lipoprotein cholesterol and cardiovascular risk
  143. Impact of coronary chronic total occlusions on long-term mortality in patients undergoing coronary artery bypass grafting
  144. Age-Dependent Effect of Left Ventricular Ejection Fraction on Long-Term Mortality in Patients With Heart Failure (from the Heart Failure Survey in ISrael)
  145. Effect of Mildly Attenuated Heart Rate Response During Treadmill Exercise Testing on Cardiovascular Outcome in Healthy Men and Women
  146. Differences in Heart Rate Profile During Exercise Among Subjects with Subclinical Thyroid Disease
  147. Mineralocorticoid receptor antagonist use in eligible patients following acute myocardial infarction: Real world data from the Acute Coronary Syndrome Israeli Surveys: 2004–2010
  148. Association of Serum Uric Acid and Cardiovascular Disease in Healthy Adults
  149. Statin Use and Reduced Cancer-Related Mortality
  150. Vascular Smooth Muscle Cells Ablation with Endovascular Nonthermal Irreversible Electroporation
  151. Principles of Tissue Engineering With Nonthermal Irreversible Electroporation
  152. Nonthermal Irreversible Electroporation for Tissue Decellularization
  153. Endovascular Nonthermal Irreversible Electroporation: A Finite Element Analysis
  154. In vivoimaging of irreversible electroporation by means of electrical impedance tomography
  155. Non Thermal Irreversible Electroporation: Novel Technology for Vascular Smooth Muscle Cells Ablation
  156. Irreversible Electroporation Attenuates Neointimal Formation After Angioplasty
  157. Intravascular irreversible electroporation: Theoretical and experimental feasibility study
  158. The Effect of Irreversible Electroporation on Blood Vessels